Cliff Asness's DYN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 84,238 shares of Dyne Therapeutics, Inc. (DYN) worth $1.53 M, representing 0.00% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in DYN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 98,965 shares. Largest reduction occurred in Q4 2024, reducing 89,198 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Dyne Therapeutics (DYN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Dyne Therapeutics (DYN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +13,579 | Add 19.22% | 84,238 | $18.13 |
| Q4 2025 | -71,216 | Reduce 50.20% | 70,659 | $19.56 |
| Q3 2025 | +98,965 | Add 230.63% | 141,875 | $12.65 |
| Q2 2025 | +19,350 | Add 82.13% | 42,910 | $9.52 |
| Q1 2025 | +23,560 | New Buy | 23,560 | $10.46 |
| Q4 2024 | -89,198 | Sold Out | 0 | $0.00 |
| Q3 2024 | +80,703 | Add 950.01% | 89,198 | $35.92 |
| Q2 2024 | +352 | Add 4.32% | 8,495 | $35.29 |
| Q1 2024 | +8,143 | New Buy | 8,143 | $28.39 |
| Q4 2023 | -11,644 | Sold Out | 0 | $0.00 |
| Q3 2023 | -8,525 | Reduce 42.27% | 11,644 | $8.96 |
| Q2 2023 | +20,169 | New Buy | 20,169 | $11.25 |
Cliff Asness's Dyne Therapeutics Investment FAQs
Cliff Asness first purchased Dyne Therapeutics, Inc. (DYN) in Q2 2023, acquiring 20,169 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Dyne Therapeutics, Inc. (DYN) for 12 quarters since Q2 2023.
Cliff Asness's largest addition to Dyne Therapeutics, Inc. (DYN) was in Q3 2025, adding 141,875 shares worth $1.79 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 84,238 shares of Dyne Therapeutics, Inc. (DYN), valued at approximately $1.53 M.
As of the Q1 2026 filing, Dyne Therapeutics, Inc. (DYN) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Dyne Therapeutics, Inc. (DYN) was 141,875 shares, as reported at the end of Q3 2025.